Samuel P. Carmichael

Samuel P. Carmichael

Auto-generated profile, based on publicly available information

Samuel P. Carmichael

Department of Surgery, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2022 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
PDF file
LKLisa Kodadek
Lisa Kodadek
SCSamuel P Carmichael
Samuel P Carmichael
ASAnupamaa Seshadri
Anupamaa Seshadri
APAbhijit Pathak
Abhijit Pathak
JHJason Hoth
Jason Hoth
RGRichard P Gonzalez
Richard P Gonzalez
Rhabdomyolysis is a clinical condition characterized by destruction of skeletal muscle with release of intracellular contents into the bloodstream. Intracellular contents released include electrolytes, enzymes, and myoglobin, resulting in systemic complications. Muscle necrosis is the common factor for traumatic and non-traumatic rhabdomyolysis. The systemic impact of rhabdomyolysis ranges from asymptomatic elevations in bloodstream muscle enzymes to life-threatening acute kidney injury and electrolyte abnormalities. The purpose of this clinical consensus statement is to review the present-day diagnosis, management, and prognosis of patients who develop rhabdomyolysis.

24 February 2021 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
PDF file
JRJoseph F Rappold
Joseph F Rappold
FSForest R Sheppard
Forest R Sheppard
SISamuel P Carmichael Ii
Samuel P Carmichael Ii
JCJoseph Cuschieri
Joseph Cuschieri
ELEric Ley
Eric Ley
CMChristopher P Michetti
Christopher P Michetti
Venous thromboembolism (VTE) is a potential sequela of injury, surgery, and critical illness. Patients in the Trauma Intensive Care Unit are at risk for this condition, prompting daily discussions during patient care rounds and routine use of mechanical and/or pharmacologic prophylaxis measures. While VTE rightfully garners much attention in clinical patient care and in the medical literature, optimal strategies for VTE prevention are still evolving. Furthermore, trauma and surgical patients often have real or perceived contraindications to prophylaxis that affect the timing of preventive measures and the consistency with which they can be applied. In this Clinical Consensus Document, the American Association for the Surgery of Trauma Critical Care Committee addresses several practical clinical questions pertaining to specific or unique aspects of VTE prophylaxis in critically ill and injured patients.

17 March 2022 in Journal of Surgical Research
Verified
Journal Article
Closed access
SCSamuel P. Carmichael
Samuel P. Carmichael
JSJaewook Shin
Jaewook Shin
JVJohn W. Vaughan
John W. Vaughan
PCPrafulla K. Chandra
Prafulla K. Chandra
JHJohn B. Holcomb
John B. Holcomb
AAAnthony J. Atala
Anthony J. Atala

1 November 2021 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
SCSamuel P. Carmichael
Samuel P. Carmichael
NLNicholas Lin
Nicholas Lin
MEMeagan E. Evangelista
Meagan E. Evangelista
JHJohn B. Holcomb
John B. Holcomb
Whole blood transfusion (WBT) began in 1667 as a treatment for mental illness, with predictably poor results. Its therapeutic utility and widespread use were initially limited by deficiencies in transfusion science and antisepsis. James Blundell, a British obstetrician, was recognized for the first allotransfusion in 1825. However, WBT did not become safe and therapeutic until the early 20th century, with the advent of reliable equipment, sterilization, and blood typing. The discovery of citrate preservation in World War I allowed a separation of donor from recipient and introduced the practice of blood banking. During World War II, Elliott and Strumia were the first to separate whole blood into blood component therapy (BCT), producing dried plasma as a resuscitative product for “traumatic shock.” During the 1970s, infectious disease, blood fractionation, and financial opportunities further drove the change from WBT to BCT, with few supporting data. Following a period of high-volume crystalloid and BCT resuscitation well into the early 2000s, measures to avoid the resulting iatrogenic resuscitation injury were developed under the concept of damage control resuscitation. Modern transfusion strategies for hemorrhagic shock target balanced BCT to reapproximate whole blood. Contemporary research has expanded the role of WBT to therapy for the acute coagulopathy of trauma and the damaged endothelium. Many US trauma centers are now using WBT as a front-line treatment in tandem with BCT for patients suffering hemorrhagic shock. Looking ahead, it is likely that WBT will once again be the resuscitative fluid of choice for patients in hemorrhagic shock.

1 October 1991 in Journal of Small Animal Practice
Verified
Journal Article
Closed access
PDF file
SCS. Carmichael
S. Carmichael

21 November 2022 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
PDF file
ASAnupamaa Seshadri
Anupamaa Seshadri
RARachel Appelbaum
Rachel Appelbaum
SCSamuel P Carmichael
Samuel P Carmichael
MFMichael Steven Farrell
Michael Steven Farrell
DFDina M Filiberto
Dina M Filiberto
CMChristopher P Michetti
Christopher P Michetti
Alcohol withdrawal syndrome is a common and challenging clinical entity present in trauma and surgical intensive care unit (ICU) patients. The screening tools, assessment strategies, and pharmacological methods for preventing alcohol withdrawal have significantly changed during the past 20 years. This Clinical Consensus Document created by the American Association for the Surgery of Trauma Critical Care Committee reviews the best practices for screening, monitoring, and prophylactic treatment of alcohol withdrawal in the surgical ICU.